ENSG at a glance
ENSIGN GROUP, INC (ENSG, SEC CIK 1125376) filed its latest 10-K annual report on February 4, 2026, a 10-Q quarterly report on October 27, 2026, an 8-K current report on October 27, 2026 and Form 4 insider filings as recently as November 10, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), ENSIGN GROUP, INC (ENSG) reported revenue of $5.0 billion (up 18.1% from FY2024) and net income of $344.0 million. Diluted EPS was $5.84.
- As of September 30, 2026, 35 institutional investment managers tracked by SignalX reported holding ENSIGN GROUP, INC (ENSG) shares worth $3.3 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Parkinson Mark Vincent on October 16, 2026 of 100 shares at $179.62 per share.
- In the last 90 days, ENSG insiders reported 0 open-market purchases ($0) and 1 open-market sale ($18K) on Form 4, a net sale of $18K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $5.0B
- +18.1% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$18K
- 13F holders
- 35 funds
- $3.3B · +1 vs prior quarter
- Latest 8-K
- Oct 27, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business: Operating and leasing skilled nursing and senior living healthcare facilities through independent subsidiaries
- New ERP system implemented in January 2026 to unify processes and enhance real-time operational data access, with risks of disruption and higher costs
- Strategic focus on expanding and diversifying real estate portfolio amid increased competition from healthcare REITs and other investors
- Operating 373 facilities, with 253 under long-term triple-net leases and $3.1 billion future operating lease obligations as of December 31, 2025
- Heightened risk from natural disasters and unionization efforts potentially increasing costs and operational challenges in independent subsidiaries
Risk Factors
- Regulatory risk from compliance with NIST SP 800-53 Rev 5 cybersecurity framework and ongoing audits
- Operational risk relying on Service Center's Chief Information Officer and Chief Information Security Officer with 24+ years IT experience
- Cybersecurity vulnerability requiring regular employee training and external consultant support for incident response
- No specific geopolitical, competitive market, or financial risks detailed in this section
Management Discussion & Analysis
- Total long-term debt declined to $144.4M in 2025 from $148.4M in 2024
- Operating lease obligations total $3.08B, with $238.5M due in 2026
- Interest payments on long-term debt expected $67.1M cumulative, $4.3M in 2026
- Cash required for self-insured liabilities not included; additional $48.0M settlement funds noted
- No explicit revenue, profit, or forward guidance disclosed in provided text
AI summary of the ENSG 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- Newly added regulatory risk: OBBB limits Medicaid funding and requires eligibility redeterminations every six months
- Most material update: CMS SFF guidance prioritizes resident falls and adds annual life-safety surveys, increasing oversight risk
- Compliance risk: 18 subsidiaries had multi-claim Medicare reviews scheduled or in process as of September 30, 2026
- Operational risk: Nine-month expansion added 23 stand-alone skilled nursing operations and two campus operations, straining management resources
- Financial risk: $3.1 billion future operating lease obligations and $60.0 million Credit Facility borrowings outstanding at September 30, 2026
Management Discussion & Analysis
- Revenue $1.484B, up 14.5% YoY from $1.296B, driven by occupancy, acuity and acquisitions
- Net income $104.4M, 7.0% margin vs 6.5%; operating margin 9.3% vs 7.4%
- Skilled services strongest segment: $1.422B revenue, segment income $185.2M vs $153.1M
- Cash used for real estate purchases; $543.1M added assets and $47.4M stock repurchases
- FY 2027 SNF payment rates, 2.4% net increase; Medicaid financing changes remain a reimbursement headwind
AI summary of the ENSG 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q3 2026 results covered quarter ended September 30, 2026, with press release issued October 27, 2026
- Exhibit 99.1 contains the financial results and detailed operating metrics investors need for performance assessment
Item EX-99.1: Item EX-99.1
- Q3 revenue $1.48B, up 14.5%, with GAAP EPS $1.76, up 23.9%, signaling strong operating leverage
- Adjusted EPS $2.03, up 23.8%, while adjusted net income reached $120.5M
Item 5.03: Amendments to Articles of Incorporation or Bylaws
- Bylaw amendments effective August 20, 2026, aligning governance procedures with Delaware law
- Advance-notice window for 2027 nominations and proposals: January 13–February 12, 2027
Item 1.01: Entry into a Material Definitive Agreement
- Revolving credit capacity increased $200 million to $800 million, expanding liquidity for acquisitions, capital needs, and working capital
- Maturity extended to August 19, 2031, reducing near-term refinancing risk
Item 2.03: Creation of a Direct Financial Obligation
- Fourth Amended and Restated Credit Agreement creates or modifies Ensign Group’s direct financial obligations
- Credit agreement terms, including borrowing capacity, interest rate and maturity, appear in Item 1.01
Item 7.01: Regulation FD Disclosure
- Fourth Amended and Restated Credit Agreement entered on August 20, 2026
- Credit facility terms and borrowing capacity require review of Exhibit 99.1
AI summaries of ENSG 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for ENSG
Don't miss the next ENSG filing
- Alerts as it files. A push when ENSG files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut ENSG, by share count.
- Ask anything. An AI agent that reads every ENSG filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Snapper Suzanne D. | F | Nov 6, 2026 | 489 | $181.08 |
| Keetch Chad | F | Nov 6, 2026 | 387 | $181.08 |
| Uychiat Pison Marivic | F | Nov 6, 2026 | 102 | $181.08 |
| Burton Spencer | F | Nov 6, 2026 | 351 | $181.08 |
| Port Barry | F | Nov 6, 2026 | 550 | $181.08 |
| Uychiat Pison Marivic | F | Nov 5, 2026 | 163 | $182.39 |
| Uychiat Pison Marivic | A | Nov 4, 2026 | 1,600 | - |
| Uychiat Pison Marivic | A | Nov 4, 2026 | 4,000 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $3.7B | $4.3B | $5.0B |
| Operating Income | $255.4M | $358.3M | $425.3M |
| Net Income | $209.4M | $298.0M | $344.0M |
| Op. Margin | 6.8% | 8.4% | 8.5% |
| Net Margin | 5.6% | 7.0% | 6.8% |
| Balance Sheet | |||
| Total Assets | $4.2B | $4.7B | $5.5B |
| Equity | $1.5B | $1.8B | $2.2B |
| ROE | 14.0% | 16.2% | 15.4% |
| Per Share | |||
| EPS | $3.65 | $5.12 | $5.84 |
| Cash Flow | |||
| Operating CF | - | $347.2M | $564.3M |
Source: XBRL data in ENSIGN GROUP, INC (ENSG)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate ENSG share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 35 | $3.32B |
| Q2 2026 | 34 | $3.48B |
| Q1 2026 | 35 | $4.92B |
| Q4 2025 | 32 | $4.16B |
| Q3 2025 | 31 | $4.33B |
| Q2 2025 | 31 | $3.78B |
| Q1 2025 | 29 | $2.22B |
| Q4 2024 | 26 | $2.04B |
- AQR Capital Management+373.1K (+275%)
- Citadel Advisors LLC+296.9K (+191%)
- BlackRock+174.8K (+3%)
- T. Rowe Price Group+69.2K (+20%)
- Bank of America Corp+28.4K (+12%)
- Vanguard Portfolio Management LLC−178.3K (-6%)
- Morgan Stanley−142.0K (-24%)
- Vanguard Capital Management LLC−107.0K (-4%)
- Goldman Sachs Group−104.2K (-23%)
- Two Sigma Investments−93.2K (-59%)
- FMR LLC (Fidelity)−2.54M
Source: 13F-HR filings on SEC EDGAR (aggregated from 253 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
ENSG filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 8-K | Oct 27, 2026 | - | Analysis | - |
| 10-Q | Oct 27, 2026 | Sep 30, 2026 | Analysis | |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 8-K | Aug 25, 2026 | - | Analysis | - |
| 8-K | Aug 20, 2026 | - | Analysis | - |
| 4 | Aug 13, 2026 | - | - | - |
| 4 | Jul 29, 2026 | - | - | - |
| 8-K | Jul 27, 2026 | - | Analysis | - |
| 10-Q | Jul 27, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Jul 22, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
| 4 | Jul 17, 2026 | - | - | - |
Related Health Care companies
- NHC · NATIONAL HEALTHCARE CORPServices-Skilled Nursing Care Facilities
- PACS · PACS Group, Inc.Services-Skilled Nursing Care Facilities
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
ENSG SEC filings: frequently asked questions
Are ENSG insiders buying or selling?
In the last 90 days, ENSIGN GROUP, INC (ENSG) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $17,962 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold ENSG stock?
As of September 30, 2026, the largest ENSIGN GROUP, INC (ENSG) holders among the 13F filers tracked by SignalX were BlackRock ($1.0 billion), Vanguard Portfolio Management LLC ($462.4 million), Vanguard Capital Management LLC ($433.0 million), State Street Corp ($313.2 million), Dimensional Fund Advisors ($169.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was ENSG's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), ENSIGN GROUP, INC (ENSG) reported revenue of $5.0 billion (up 18.1% from FY2024) and net income of $344.0 million. Diluted EPS was $5.84. The figures come from the XBRL data in the 10-K.
What are the main risks in ENSG's latest 10-K?
In the 10-K filed February 4, 2026, ENSIGN GROUP, INC (ENSG) flagged: Regulatory risk from compliance with NIST SP 800-53 Rev 5 cybersecurity framework and ongoing audits. Operational risk relying on Service Center's Chief Information Officer and Chief Information Security Officer with 24+ years IT experience. (AI summary of the Risk Factors section.)
What did ENSG report in its latest 8-K?
ENSIGN GROUP, INC (ENSG) filed an 8-K on October 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 2026 results covered quarter ended September 30, 2026, with press release issued October 27, 2026.
What are the latest ENSG SEC filings?
ENSIGN GROUP, INC (ENSG) filed its latest 10-K annual report on February 4, 2026, a 10-Q quarterly report on October 27, 2026, an 8-K current report on October 27, 2026 and a Form 4 insider filing on November 10, 2026.
What is ENSG's SEC CIK number?
ENSIGN GROUP, INC (ENSG)'s SEC Central Index Key (CIK) is 1125376. EDGAR lists every ENSG filing under that number.
Ask anything about ENSG
The research agent reads ENSG's filings, financials, insider trades and 13F holders, then answers with sources.